Searched for
NOVARTIS INTERNATIONAL AG
Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...- JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 croreJB will pay Rs 964 crore for the portfolio licensing agreement with Novartis Innovative Therapies AG which the company said is "perpetual i...
- Medical companies seek G-20 protection for patentsThe warning comes in a report prepared for G-20 leaders by representatives of health and life-sciences companies including Novartis AG, San...
- Novartis pays $678 million to resolve suit over sham doctor outingsThe settlement of the lawsuit was announced by Acting Manhattan U.S. Attorney Audrey Strauss, who said the company splurged on "speaking fe...
- India won't participate in unilateral US probe on IPRIndia today made it clear it will not take part in any unilateral investigation by the US on its intellectual property rights (IPR).
- ISB receives 831 job offers from Apple, Accenture, Cognizant, BCG, Google and others in its ongoing placementsThe Indian School of Business (ISB) has already received 831 job offers for its batch of 2014. This is a 19% increase over 697 offers made ...
- US trade panel launches probe against India's trade policiesUS Federal agency USITC today started a fact finding probe into impact of Indian trade and investment policies on the American economy.
- SC decision on Novartis "historic": Anand SharmaSharma today described the SC judgement rejecting Novartis AG plea for its cancer drug as "historic" and said Indian Patent Law conforms fu...
- Indian women entrepreneurs building businesses on a grand scale across multiple sectorsAs Facebook’s Sheryl Sandberg asks women across the world to “lean in” to their careers, her ideas are finding resonance in an unlikely qua...
- Cipla scouting for outside talent, focus on Africa deliver the goodsThe company’s improved performance over the last four quarters is a testimony to the fact that these changes are paying off.
- Novartis India Q1 net up 19.15 pc at Rs 37.57 crDrug firm Novartis India on Monday said its net profit for the quarter ended June 30, 2011 rose by 19.15 per cent to Rs 37.57 crore.
- Novartis India Q3 net up 74.94 pc to Rs 40.50 crDrug firm Novartis India today said its net profit rose by 74.94 per cent to Rs 40.50 crore for the third quarter ended December 31, 2010, ...
- Jupiter Biosciences in talks to buy Swiss pharma co for $10 mHyderabad-based Jupiter Biosciences is in talks to buy privately held Swiss pharma company SynphaBase AG for about $10 million as it looks ...
- Novartis hikes offer price for arm to Rs 450Novartis AG, the Swiss pharma giant, has increased the open offer price for its subsidiary Novartis India to Rs 450 from Rs 351 per share.
- Heard on the streetThe decision to suspend futures trade in the commodity has hit investors, hedgers and speculators, who were long on the commodity.
- Novartis' open offer hangs in balanceThe fate of the open offer of Swiss pharma giant Novartis to scale up its stake in its Indian subsidiary Novartis India looks uncertain wit...
- Retailers end boycott of NovartisOver 7,000 retailers and stockists had stopped selling all the 198 medicines of two firms from April 1, protesting the drugmakers’ practice...
- Bill Gates joins Gordon Brown's new global health planSoftware tycoon Bill Gates gave his backing to a new initiative unveiled by British Prime Minister Gordon Brown to tackle killer diseases i...
- Madras HC to rule on Novartis’ patent caseWhen Novartis AG was accused of jeopardising patients’ access to generic medicines in India last year, the Swiss drug giant thought it woul...
- Novartis takes on patent law in Glivec caseFollowing rejection of its patent application for anti-cancer drug Glivec, Swiss pharmaceutical giant Novartis AG is not only challenging t...
Load More
